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Abstract 
Introduction: Various objective scoring systems were developed to standardize the approach to the designation of severity of community-
acquired pneumonia (CAP). There is limited data on the use of CURB-65 among admitted CAP patients in Saudi Arabia.   
Methodology: The retrospective study included CAP patients, admitted to a general hospital in Eastern Saudi Arabia. The CURB-65 was 
extracted from the available medical records. 
Results: During the study period, from 2013 to 2016, a total of 1786 adults were admitted with a mean age of 63.9 ± 21.7 (range 14-108 years). 
The majority of the patients (51.7%) had CURB-65 score 0 or 1 followed by the score 2, 3 and 4/5 (29%, 15.2%, and 4.1%, respectively).  The 
mean CURB-65 was 1.4 ± 1.12 for those who survived and 2.27 ± 1.03 for those who died (p < 0.001). The mean age was 63.01± 21.9 years 
for survived patients and 75.1 ± 15.58 years for fatal cases (p < 0.001). The overall 30-day crude mortality rate was 7.6%. The mortality rates 
for CURB-65 scores 0, 1, 2, 3, and 4/5 were 1.8%, 4.3%, 10.2%, 14%, and 21.9%, respectively. 
Conclusions: The mortality rates of admitted patients with CAP did not differ from those reported in the literature. However, the utilization of 
CURB-65 score was low and there is a need for wider implementation of pneumonia severity index for patients presenting with CAP. 
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Introduction 
Community-acquired pneumonia (CAP) is a 
common diagnosis leading to admissions throughout 
the world and remains a cause of substantial morbidity 
and mortality worldwide.  CAP is also important as it 
may lead to respiratory failure and may result in death. 
Various objective scoring systems were developed to 
standardize the approach to designation of the severity 
of CAP. These criteria help in the calculation of the 
expected mortality rate and thus inform the clinician on 
the need for hospital admission. The recent CAP 
guidelines state that major decisions regarding 
diagnostic and treatment issues of CAP spin around 
initial assessment of severity using a scoring system [1]. 
There are four proposed pneumonia severity scores: the 
Pneumonia Severity Index (PSI) [2], the Infectious 
Diseases Society of America (IDSA)/American 
Thoracic Society (ATS) severe pneumonia criteria [1], 
CURB-65 [3] and the Japanese Respiratory Society 
(JRS) scores [4]. The JRS scores relies on physiological 
and radiological criteria (radiological extent, 
temperature, pulse rate, respiratory rate and 
dehydration) and laboratory data (WBC count, C-
reactive protein value and PaO2 or SpO2 value) [4]. 
Another scoring system is the expanded-CURB-65 
(CURB-65, lactate dehydrogenase, platelet, and 
albumin) [5]. The CURB-65 score components include 
scoring patient based on confusion, blood urea, 
respiratory rate, blood pressure, and age ≥ 65 years 
[3,6]. The score had been associated with mechanical 
ventilation, rate of hospital admission, and duration of 
hospital stay among hospitalized patients [7]. Based on 
local guidelines, CURB-65 should be used for 
hospitalized patients and that hospitalization is 
recommended for patients with CURB-65 score of ≥ 2 
[8,9]. However, there is a limited data on the use of 
CURB-65 among CAP patients in Saudi Arabia [10]. 
Thus, in this study we analyze the pattern of the CURB-
65 severity score for CAP in patients hospitalized in one 
medical center in Saudi Arabia. We also tried to 
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The medical record of patients admitted with CAP 
were obtained from the health information unit from 
2013 to 2016.  The patients’ data were collected using 
a standard Microsoft Excel data collection sheet and the 
data were obtained from paper charts and electronic 
medical records.  The Excel sheet contained 
information regarding the CURB-65 and the mortality 
within 30 days of the admission. CURB-65 score was 
calculated as having a score of one for the presence of 
each one of the following items at the time of 
admission: confusion, Blood urea ≥ 19 mg/dL, 
respiratory rate of ≥ 30/minute, a systolic blood 
pressure (BP) <90 mmHg or diastolic BP ≤ 60 mmHg, 
age ≥ 65 years, as described previously [3,6]. The study 
was approved by the Institutional Review Board (IRB). 
 
Statistical Analysis 
Statistical analysis was done using Excel. 
Descriptive analyses were done for demographic, 
results of the tests and the monthly number of cases. 
Minitab (Minitab Inc. Version 17, PA 16801, USA; 
2017) was used to calculate the mean age (± SD) of 
patients and the comparison between those who died 
and those who survived.  One-way ANOVA was used 
for the Age versus CURB-65 score comparison, and 
Chi-Square test for association between CURB-65 and 




During the study period, a total of 1786 adults were 
admitted with CAP. The mean age was 63.9± 21.7 years 
(range 14-108 years). The majority of the patients 
(51.7%) had CURB-65 score 0 or 1 followed by score 
of 2, 3, and 4/5 (29%, 15.2%, and 4.1%, respectively) 
(Table 1). The overall 30-day crude mortality rate was 
7.6%. The mortality rates for CURB-65 scores 0, 1, 2, 
3, and 4/5 were 1.8%, 4.3%, 10.2%, 14%, and 21.9% 
(Table 1). The mean age was 63.01 ± 21.9 years for 
survived patients and 75.1 (± 15.58) for the fatal cases 
(p < 0.001) (Table 2). The mean CURB-65 was 1.41 ± 
1.12 for those who survived and 2.27 ± 1.03 (p < 0.001) 
for those who died (Table 2). There was a clear 
relationship between mean age and CURB-65 score 
with increasing mean age as the CURB-65 
increases(Figure 1).  
 
Discussion 
This study describes the CURB-65 score among 
1786 admitted adults with CAP in a Saudi Arabian 
hospital. The majority (51.7%) of the patients had 
CURB-65 score of 0 or 1. The overall mortality rate was 
7.1% and was similar to a recent study describing the 
mortality rate of 6.7% among 1834 CAP patients [11]. 
The specific mortality rates for CURB-65 scores of 
0, 1, 2, 3 and for 4/5 were 1.4%, 4.1%, 9.8%, 13.2%, 
and 20.5%, respectively.  Thus, the CURB-65 score and 
calculated mortality rates mirror those described 
Figure 1. Interval Plot of Mean Age (± SD) versus CURB-65 
Score. 
Table 1. Percentage of different CURB-65 score and the mortality rate in relation to CURB-65 Score. 
CURB-65 Score Number of patients 
% from the total 
number 
Number of death 
Mortality Rate 
(%) 
Mortality from the 
Literature [3] 
0 438 24.5 8 1.8 0.6 
1 485 27.2 21 4.3 2.7 
2 518 29.0 53 10.2 6.8 
3 272 15.2 38 14.0 14 
4 or 5 73 4.1 16 21.9 27.8 
All 1786 100 136 7.6  
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previously [3,6]. However, almost half of the admitted 
patients had a score of 0 or 1. Those patients are 
recommended to be treated as outpatient as the 
associated mortality rate is low [3].  Patients with a 
score of 2 needs regular ward admission and patients 
with a score of 3-5 would require intensive care unit 
admission [3]. There might be other reasons for the 
admission of patients with low CURB-65 score in the 
current study. However, these reasons were not 
specifically sought but could be related to the routine 
screening for Middle East Respiratory Syndrome 
Coronavirus (MERS-CoV). Our hospital was of the first 
hospitals in the region to adopt a standardized screening 
for MERS-CoV [12–14]. Such screening may had then 
resulted in routine admissions of those patients. The 
Saudi Arabian Ministry of Health guidelines allow 
home isolation of patients suspected to have mild 
MERS-CoV infection [15–17]. However, the logistics 
of home isolation and the fear of spread of MERS-CoV 
influence decisions regarding the admission of such 
patients [12,18]. Previously published studies did not 
show differentiating factors among patients with MERS 
and those without MERS [12,18]. Thus, the lack of 
predictors of MERS on presentation makes this 
distinction difficult to achieve. The current study did 
not evaluate other factors influencing admissions such 
as ability to safely and reliably take oral medication and 
the availability of outpatient support resource as 
suggested by recent guidelines [1]. Routine use of 
CURB-65 score is advised, however, the actual practice 
in this part of the World is not well documented.  In one 
study from Oman, CURB-65 severity score was 
documented for only 2.3% of hospitalized patients [19].  
In a study from Nigeria, none of 249 CAP patients had 
CURB-65 score documentation in hospital notes [20]. 
Thus, there is a need to have more education with audit 
and feedback to utilize CAP severity scores in order to 
make informed decisions about the need for admission.  
Pneumonia severity index (PSI) was thought to be 
superior to the British Thoracic Society’s CURB-65 
and the modified American Thoracic Society criteria in 
predicting CAP severity [21]. Nevertheless, CURB-65 
score remains an easy score to obtain with excellent 
prediction ability. The CORB score (acute Confusion, 
Oxygen saturation ≤90%, Respiratory rate > 30/minute, 
and Systolic Blood pressure < 90 mm Hg or a diastolic 
blood pressure < 60 mm Hg was proposed for elderly 
patients.  In one study,  the CORB score was a useful 
tool for hospitalized elderly patients [22]. 
 
Conclusion 
The mortality rates of admitted patients with CAP 
did not differ from those in the medical literature. 
However, the utilization of CURB-65 score seems to be 
low and there is a need for wider implementation of 
pneumonia severity scores for patients presenting with 
CAP in our hospital.  There is a need for further 
prospective studies to elucidate the features and 
characteristics of patients with low CURB-65 scores 
needing admission. This approach would then enhance 
the optimal utilization of services and proper placement 
of patients. Further studies should also be directed 
towards comparing low and high CURB-65 score 
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